Family history of melanoma and Parkinson disease risk.

Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76

Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology (2012) 1.72

Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49

Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology (2011) 1.45

Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet (2010) 1.21

Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. Neurobiol Aging (2013) 1.17

Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma. PLoS One (2010) 1.17

Rotating night shifts and risk of skin cancer in the nurses' health study. J Natl Cancer Inst (2011) 1.08

Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One (2011) 1.02

Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease. Int J Cancer (2012) 1.02

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One (2012) 0.98

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol (2015) 0.97

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Mov Disord (2010) 0.96

Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci (2012) 0.87

No association between Parkinson disease alleles and the risk of melanoma. Cancer Epidemiol Biomarkers Prev (2011) 0.86

Melanin affinity and its possible role in neurodegeneration. J Neural Transm (Vienna) (2013) 0.86

Parkinson's disease and cancer: A register-based family study. Am J Epidemiol (2013) 0.85

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation. Alzheimers Dement (2016) 0.83

Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay. PLoS One (2014) 0.82

High prevalence of malignant melanoma in Israeli patients with Parkinson's disease. J Neural Transm (Vienna) (2011) 0.81

The associations between Parkinson's disease and cancer: the plot thickens. Transl Neurodegener (2015) 0.81

The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder. Neurobiol Aging (2016) 0.77

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease. Neurobiol Aging (2016) 0.75

Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease. Front Hum Neurosci (2015) 0.75

Red hair, MC1R variants, and risk for Parkinson's disease - a meta-analysis. Ann Clin Transl Neurol (2017) 0.75

Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma. Neurol Genet (2016) 0.75

Parkinson's disease I: glucocerebrosidase mutations, family history of melanoma and questionable effects of rasagiline. J Neurol (2009) 0.75

Family history of melanoma and Parkinson disease risk. Neurology (2010) 0.75

Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells. Oncotarget (2017) 0.75

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09

Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA (2004) 2.99

Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol (2009) 2.78

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (2005) 2.63

Meta-analysis of epidemiologic dose-response data. Epidemiology (1993) 2.54

Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol (2007) 2.53

Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol (1997) 2.14

Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89

Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer (2005) 1.72

Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer (2006) 1.71

Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69

Risk factors and individual probabilities of melanoma for whites. J Clin Oncol (2005) 1.65

Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control (2003) 1.57

Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature. J Am Acad Dermatol (1997) 1.50

Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol (2005) 1.49

Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.38

Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology (2006) 1.36

Erectile function and risk of Parkinson's disease. Am J Epidemiol (2007) 1.15

The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol (2007) 1.07

Multiple primary melanoma following administration of levodopa. Arch Pathol (1972) 1.06

Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism Relat Disord (2003) 1.05

Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies. Med Hypotheses (2008) 1.02

Malignant melanoma in early Parkinson's disease: the DATATOP trial. Mov Disord (2007) 0.99

Treatment with levodopa and risk for malignant melanoma. Mov Disord (2007) 0.98

Expression of cell cycle regulators in human cutaneous malignant melanoma. Melanoma Res (1999) 0.97

Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes Control (2007) 0.95

Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003. Eur J Cancer (2008) 0.92

Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons. Neuroscience (2007) 0.92

Levodopa and the risk of melanoma. Lancet (2007) 0.86

Levodopa therapy and the risk of malignant melanoma. Ann Pharmacother (2000) 0.83

Inhibition of CDKs: a strategy for preventing kainic acid-induced apoptosis in neurons. Ann N Y Acad Sci (2003) 0.83

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature (2003) 10.97

Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem (1995) 9.56

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development (2000) 8.07

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science (1995) 7.87

Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

The p38 signal transduction pathway: activation and function. Cell Signal (2000) 6.18

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J (1997) 4.51

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Vitamin D intake and incidence of multiple sclerosis. Neurology (2004) 4.39

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem (1995) 4.36

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29

A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12

Physical activity and risk of stroke in women. JAMA (2000) 3.95

Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91

Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 3.80

Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76

Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem (1996) 3.63

Prospective study of military service and mortality from ALS. Neurology (2005) 3.59

A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40

A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst (1994) 3.32

A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28

Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst (1995) 3.24

Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA (1999) 3.21

HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol (1999) 3.21

Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10

Plasma urate and risk of Parkinson's disease. Am J Epidemiol (2007) 3.06

Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92

Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res (1994) 2.84

Adiposity and mortality in men. Am J Epidemiol (2000) 2.60

Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J (2000) 2.53

Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem (1997) 2.47

Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A (2001) 2.46

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis (2008) 2.45

PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44

MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther (2008) 2.43

Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol (2001) 2.42

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology (2008) 2.41

Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients. Aliment Pharmacol Ther (2013) 2.38

Primitive deuterostomes from the Chengjiang Lagerstätte (Lower Cambrian, China). Nature (2001) 2.31

Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev (2000) 2.21

Hemiballismus. AJNR Am J Neuroradiol (1994) 2.16

Primary structure of BMK1: a new mammalian map kinase. Biochem Biophys Res Commun (1995) 2.15

Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials. Diabet Med (2010) 2.12

Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation (1994) 2.10

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab (2006) 2.05

Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem (1998) 2.05

Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99

The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun (1996) 1.99

Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr (2000) 1.99

Poor oral health and coronary heart disease. J Dent Res (1996) 1.92

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci (2001) 1.90

Physical activity and the risk of Parkinson disease. Neurology (2005) 1.89

Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88

Bronchial stenosis due to anthracofibrosis. Chest (1998) 1.87

Geographic variation of MS incidence in two prospective studies of US women. Neurology (1999) 1.87

Ancestral echinoderms from the Chengjiang deposits of China. Nature (2004) 1.85

NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J (1997) 1.84

Endoscopic removal of biliary self-expandable metallic stents: a prospective study. Endoscopy (2006) 1.83

The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc Natl Acad Sci U S A (1997) 1.83

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology (2010) 1.82

Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol (1997) 1.81

Multiple sclerosis and age at infection with common viruses. Epidemiology (2001) 1.80

Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology (2002) 1.75

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Exp Neurol (2003) 1.75

Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol (1996) 1.74

A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74

Head and backbone of the Early Cambrian vertebrate Haikouichthys. Nature (2003) 1.73

Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology (2012) 1.72

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis (1994) 1.71

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut (1995) 1.67

Trans fatty acids: are the effects only marginal? Am J Public Health (1994) 1.67

Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci (1989) 1.65

Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology (2008) 1.62

Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology (2007) 1.59

Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J (1966) 1.58

Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol (2006) 1.58

Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes (Lond) (2011) 1.58

Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57

Capping protein terminates but does not initiate chemoattractant-induced actin assembly in Dictyostelium. J Cell Biol (1997) 1.57

Actin filaments are severed by both native and recombinant dictyostelium cofilin but to different extents. Cell Motil Cytoskeleton (2000) 1.57

Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol (2004) 1.57